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Background: Histone to protamine exchange and the hyperacetylation of the remaining histones are hallmarks of
spermiogenesis. Acetylation of histone H4 at lysine 12 (H4K12ac) was observed prior to full decondensation of
sperm chromatin after fertilization suggesting an important role for the regulation of gene expression in early
embryogenesis. Similarly, DNA methylation may contribute to gene silencing of several developmentally important
genes. Following the identification of H4K12ac-binding promoters in sperm of fertile and subfertile patients, we
aimed to investigate whether the depletion of histone-binding is associated with aberrant DNA methylation in
sperm of subfertile men. Furthermore, we monitored the transmission of H4K12ac, 5-methylcytosine (5mC) and
5-hydroxymethylcytosine (5hmC) from the paternal chromatin to the embryo applying mouse in vitro fertilization
and immunofluorescence.
Results: Chromatin immunoprecipitation (ChIP) with anti-H4K12ac antibody was performed with chromatin isolated
from spermatozoa of subfertile patients with impaired sperm chromatin condensation assessed by aniline blue
staining. Fertile donors were used as control. DNA methylation analysis of selected H4K12ac-interacting promoters
in spermatozoa was performed by pyrosequencing.
Depletion of binding sites for H4K12ac was observed within the following developmentally important promoters:
AFF4, EP300, LRP5, RUVBL1, USP9X, NCOA6, NSD1, and POU2F1. We found 5% to 10% hypomethylation within CpG
islands of selected promoters in the sperm of fertile donors, and it was not significantly altered in the subfertile
group. Our results demonstrate that the H4K12ac depletion in selected developmentally important promoters of
subfertile patients was not accompanied by a change of DNA methylation.
Using a murine model, immunofluorescence revealed that H4K12ac co-localize with 5mC in the sperm nucleus.
During fertilization, when the pronuclei are formed, the paternal pronucleus exhibits a strong acetylation signal
on H4K12, while in the maternal pronucleus, there is a permanent increase of H4K12ac until pronuclei fusion.
Simultaneously, there is an increase of the 5hmC signal and a decrease of the 5mC signal.
Conclusions: We suggest that aberrant histone acetylation within developmentally important gene promoters in
subfertile men, but not DNA methylation, may reflect insufficient sperm chromatin compaction affecting the
transfer of epigenetic marks to the oocyte.
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The classic definition of infertility for both, men and
women, states a disability to conceive within 12 months,
despite frequent unprotected sexual intercourse. About
15% of couples have difficulties to become pregnant, and
in approximately 30% of these couples, it is only the
man who is diagnosed with reproductive problems [1].
There is a growing population of men with infertility
disorders, having a decreased number of sperm cells in
the ejaculate, as assessed by sperm analysis (oligozoos-
permia), or no sperm cells present in the ejaculate (azoo-
spermia) [2]. Over 80% of men suffering with infertility
have a low sperm concentration associated with de-
creased sperm motility and a normal sperm morphology
(asthenozoospermia). Others may have decreased sperm
motility and also abnormal sperm morphology (terato-
zoospermia). Besides severe forms of male infertility,
which is referred to as azoospermia, reduced fertility
may also have unexplained reasons and this is termed as
subfertility or idiopathic infertility [3]. At the present
time, there are multiple assisted reproductive technics
(ART) available, which provide effective treatment of
male subfertility and result in successful fertilization.
Nevertheless, genetic and epigenetic defects, as well as
abnormalities in sperm chromatin structure, represent a
major problem for reproductive medicine, because in
contrast to sperm count and motility impairments, sperm
chromatin and DNA failures cannot be overcome, even,
by applying intracytoplasmic sperm injection (ICSI).
During spermiogenesis, DNA-binding histones are
replaced by protamines. As nucleoprotamine package
DNA is approximately ten times more efficient than
nucleohistones, transcription stops in elongating sper-
matids. In men, histone to protamine exchange is in-
complete and the remaining histones are located in the
annular region and are highly acetylated [4,5]. Although
histone acetylation is a characteristic feature of tran-
scriptional active genes, it is known that spermatozoa
are transcriptionally inactive [6]. This obvious inconsist-
ency resulted in the hypothesis that histone acetylation
represents an epigenetic mark that is transmitted from
sperm to oocyte and involved in the regulation of gene
expression in the early embryo. In the murine zygote,
histone variants H2AX, H3.3, H4K8ac, and histone H4
acetylated at lysine 12 (H4K12ac) were demonstrated
prior to full decondensation of the sperm nucleus and
any substitutions by maternal factors [7] indicated that
they must have originated from the sperm [7-9].
Hammoud et al. [10] and Arpanahi et al. [11] were the
first who performed deep sequencing and comparative
genome hybridization of the sperm genome, respectively,
and reported that remaining nucleosomes are enriched
at loci of developmental importance, including imprinted
gene clusters, HOX gene clusters, and microRNA clustersand promoters of developmental transcription and sig-
naling factors. Developmental loci, in addition, were as-
sociated with H3K4me2 and H3K4me3 [10]. Authors
postulated that the transmission of paternal epigenetic
information by modified histones may be dependent on
the binding position around the transcriptional start site
(TSS) and the size of the region interacting with a
distinct modification. This hypothesis was supported by
ontology analyses showing that developmental gene func-
tions are more over-represented among genes which are
more broadly marked by H3K27me3 in spermatozoa. Sub-
sequently, our group demonstrated that binding intensities
for H4K12ac, on average, were highest between 0 and
2 kb downstream to the TSS [12]. Using data from
Hammoud et al. [10], Vavouri and Lehner [13] re-
ported that nucleosome retention occurs preferentially
at GC-rich sequences. This was confirmed by Hisano
et al. [14] in mice. A recent study in men and bulls
demonstrated that the vast majority of retained nucle-
osomes are located within distal intergenic regions and
introns are associated with centromere repeats and
retrotransposons, while 5′-UTRs, 3′-UTRs, TSSs, and
TTSs were depleted from nucleosomes [15]. At the
same time, Carone et al. [16] reported different results
for nucleosome retention in mice depending on the
method of nucleosome collection.
Besides modification of histones, methylation of sperm
DNA may be involved in the chromatin repackaging
process. Three structurally distinct chromatin configu-
rations may occur as follows: histone-packaged hypo-
methylated DNA, histone-packaged methylated DNA,
and protamine-packaged hypomethylated DNA [17].
Bioinformatic alignments of H4K12ac chromatin im-
munoprecipitation assay in combination with micro-
array (ChIP-chip) data [11] with sperm methylome
[18] provided the first overview of H4K12ac association
with methylated or unmethylated gene promoters. On a
genome-wide scale, H4K12ac-associated sequences closely
co-localized with promoter hypermethylation clusters. As
global methylation of gene sequences is a known feature
of mature sperm chromatin, the correspondence between
gene density and DNA methylation was not unexpected.
However, exceptions to the trend for promoter methyla-
tion include the developmentally important HOX gene
clusters and the PAX genes [17].
Based on our previous studies [7,13], where we analyzed
genome-wide binding sites for H4K12ac in the sperm of
healthy donors, we now investigated whether subfertile
patients with incomplete sperm chromatin condensation
exhibit aberrant binding of H4K12ac to selected gene pro-
moters. To analyze whether epigenetic marks may be
transmitted from the sperm to the zygote, we investigated
the co-localization of H4K12ac with 5-methylcytosine
(global methylation) and 5-hydroxymethylcytosine in
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DNA methylation of developmental gene promoters
associated with H4K12ac may be involved in male
infertility, we compared methylation levels of single
CpGs within CpGs islands of nine selected H4K12ac-
bound promoters (AFF4, AXIN1, EP300, LRP5, RUVBL1,
USP9X, NCOA6, NSD1, POU2F1) between healthy do-
nors and subfertile patients.
Results
Loss of H4K12ac promoter binding in sperm DNA of
subfertile patients
Based on the results obtained from ChIP-chip analysis
with H4K12ac from fertile donors and semen samples of
subfertile patients, as well as gene ontology classifica-
tions, we were able to select fertility/developmentally
relevant sperm promoters that lack interaction with
H4K12 in sperm DNA of subfertile patients. Selected
gene promoters are listed in Table 1.
Our genome-wide analysis showed no significant peak
corresponding to an enrichment of the binding site
(FDR-false discovery rate) of all of selected promoters
AFF4 and NSD1 (Figure 1A, D). Peaks of other investi-
gated promoters POU1F2, NCOA6, LRP5, EP300, USPX9,
and RUVBL1 are shown in Additional file 1.
Using μChIP, which is optimized for minimum input
material corresponding to 1 million sperm cells, we identi-
fied binding sites for nine H4K12ac-associated or depleted
promoters in sperm of subfertile patients and fertile do-
nors, respectively. μChIP assay showed an overall decrease
in the binding capacity of H4K12ac to the investigated
DNA sequences in subfertile patients when compared toTable 1 Summary of H4K12ac lacking promoters in spermato
Function of promoters depleted for H4K12ac binding in sperm chroma
AFF4 AF4/FMR2 family member 4, AFF4-deficient mice male m
azoospermia and their outcomes died in utero and neon
embryonic development.
NCOA6 Nuclear receptor co-activator 6; involved in the co-activa
nuclear receptors, such as for steroids (GR and ERs), retin
RXRs), thyroid hormone (TRs), vitamin D3 (VDR), and pros
RUVBL1 RuvB-like 1, TATA box-binding protein-interacting protein
the NuA4 histone acetyltransferase complex.
NSD1 Histone methyltransferase, methylates ‘Lys-36’ of histone
histone H4 (in vitro). Transcriptional intermediary factor c
negatively or positively influencing transcription. Defects
cause of Beckwith-Wiedemann syndrome.
EP300 Histone acetyltransferase p300; regulates transcription via
remodeling.
LRP5 Low-density lipoprotein receptor-related protein 5; forms
oligomer aggregates on Wnt-signaling. Required for post
of the epiblast during gastrulation.
POU2F1 POU domain, class 2, transcription factor 1. Transcription
to the octamer motif (5′-ATTTGCAT-3′) and activates the
the genes for some small nuclear RNAs.fertile donors (Figure 2). A significant decrease of enrich-
ment has been detected in NCOA61 (P = 0.0076), POU2F1
(P = 0.01), and NSD1 (P = 0.006). In AFF4, RUVBL1, and
POU2F promoters, the decrease of H4K12ac enrich-
ment was accompanied by a decrease of H3 enrichment
(Figure 2). Regarding the NSD1 promoter, we observed
enrichment of H4K12ac in all ejaculates from healthy
donors (n = 5) (Figure 3). In contrast, in four out of
eight subfertile patients, no enrichment of the NSD1
promoter could be observed (Figure 3B). Reduced en-
richment was observed in eight patients. Interestingly,
the enrichment of unmodified histone H3 was not altered
in the subfertile group. In four out of eight patients, a lack
of H4K12ac binding was possibly compensated by pro-
tamine enrichment to the NSD1 locus (Figure 3C).
H4K12ac-associated promoters are poised by DNA
hypomethylation
Investigating the level of a single CpG methylation by
using a highly sensitive pyrosequencing method, we
could demonstrate the hypomethylation of DNA in all
H4K12ac interacting promoters. For each promoter, the
region containing 6 to 12 CpGs was covered by pyrose-
quencing of 1 to 3 polymerase chain reaction (PCR)
products. The number of analyzed CpGs was as follows:
AFF4 - 12 CpGs; EP300 - 5 CpGs; LRP - 6CpGs;
NCOA6 - 6 CpGs; RuVBL1 -5 CpGs; USP9X - 5CpGs;
POU2F1 - 5CpGs; and NSD1 - 12 CpGs. For an internal
control, a fully methylated and unmethylated sodium
bisulphite converted DNA was included. In addition, py-
rosequencing of paternally imprinted and hypermethy-
lated locus of H19 was carried out (Figure 4). A lowzoa of subfertile patients
tin of subfertile patients References
ice are sterile with
atally with impaired
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oids (RARs and
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Figure 1 Methylation analysis of the selected H4K12ac interacting promoters. (A, D) The enrichment of binding sites for H4K12ac AFF4
and NSD 1 in sperm chromatin of fertile and subfertile men (ChIP-chip assay Hg18 NimblGene). ChIP-chip, chromatin immunoprecipitation assay
in combination with microarray. Each feature on the array had a corresponding scaled log2 ratio that was calculated from the input signal Cy3
for the total of chromatin and IP probe - Cy5, which were co-hybridized to the array. The log2 ratio was computed and scaled to the center the
ratio data around zero. Scaling was performed by subtracting the bi-weight mean of the log2 ratio values for all features on the array from each
log2 ratio value. The binding sites for H4K12ac to sperm chromatin were detected by searching for four or more oligo probes whose signals were
above the specific cut off values, ranging from 90% to 15%, using a 500-bp sliding window. The ratio data were randomized 20 times, and each
peak was assigned a false discovery rate (FDR) score based on the randomization. The lower the FDR score, the more likely the peak corresponded to
a H4K12ac binding site. Data are visualized using SignalMap browser (NimbleGen). (B, E) Genomic position of analyzed CpGs within CpG islands of
AFF4 and NSD1 - pyrosequencing. (C, F) Methylation levels of each investigated CpG in sperm DNA of fertile and subfertile patients.
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detected in the sperm of donors and subfertile patients.
We observed a significant decline of methylation in the
AFF4 promoter in position CpG 1 (2.8% ± 1.2% vs. 1.9%
± 0.9%; P = 0.016) in the subfertile group (Figure 1). In
the EP300 promoter, consistent 5% methylation was
detected in the group of fertile men, while in several
subfertile men, methylation increased up to 17%. A sig-
nificant decrease in methylation was observed in CpG 3
(6.44% ± 2.7% vs. 4.6% ± 2.5%; P = 0.01) and CpG4 (4.0%
± 1.5% vs. 3.0% ± 1.7%; P = 0.04) of the LRP promoter
(Additional file 1). The value of CpGs methylation in
NCOA6, RuVBL1, USP9X, and POU2F1 promoters didnot exceed 5% on average, and the standard deviations
were low in the group of fertile donors. In the NSD1
promoter, there were significant differences in the pos-
ition of CpG2 (3.3% ± 1.0% vs. 2.54% ± 4.1%; P = 0.005)
and CpG 11 (4.3% ± 3.7% vs. 1.7% ± 1.0%; P = 0.003). We
observed a different methylation pattern among subfer-
tile patients; however, the CpG methylation levels varied
between 5% to 20%, which is considered as hypomethy-
lation (Additional file 1).
In all H4K12ac-associated promoters, no significant
difference was detected regarding the cumulative CpG
methylation of the investigated promoters despite NSD1
(4.1% ± 1.0% vs. 2.6% ± 1.9%; P = 0.004) (Figure 5). The
Figure 2 Validation of enriched promoters with μChIP in combination with real-time polymerase chain reaction (PCR) between sperm
of fertile donors and subfertile patients. Results from ChIP assay with anti-H4K12ac antibodies, with anti-protamine-1 in immunoprecipitated
DNA of fertile donors (n = 5) and subfertile patients (n = 8). Unmodified H3 was used as a positive and IgG as a negative isotype control. Loss of
interaction for H4K12ac was detected in selected promoters; however, a significant difference was observed in NCOA6, RUVBL1, and POU2F1.
Depletion of H4K12ac binding is potentially replaced by either unmodified histone H3 or protamine 1.
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Figure 3 μChIP assay in combination with real time qPCR demonstrating loss of association of NSD1 promoter sequence with H4K12ac in
subfertile patients with aberrant sperm chromatin condensation. (A) Representative qPCR demonstrating enrichment of μChIP experiments with
anti-H4K12ac antibodies, with anti-protamine-1 antibodies from input material in individual fertile donors (fc= 5) and (B) subfertile patients (n = 8).
Unmodified H3 was used as a positive and IgG as a negative, isotype control. (C) Enrichment of the immunoprecipitated sample from fertile and
subfertile men compared to input materials was calculated as follows: ΔCt = Ct (input) - Ct (immunoprecipitated sample) and % total = 2ΔCt × 10
(according to 10% input chromatin of total immunoprecipitated chromatin). Depletion of binding and an increase of protamine occupancy to the
NSD1 promoter were detected.
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ciated with H4K12ac, displayed an opposite methylation
pattern. Twelve CpGs of protamine 1/2 common CpG
island have been highly methylated (40% to 100%);however, no changes in subfertile patients were detected
(Figure 6).
The association of DNA methylation of H4K12ac-
binding promoters with clinical parameters (Table 2) did
Fertile
donor
Infertile 
patient 1
NSD1:
Sequence to analyze: 
GGTTTYGTTGGTYGTTTYGGTTTTTTTTTTTGTYGGGT
control - 
methylated
DNA
control - 
unmethylated 
DNA
H19:
Sequence to analyze: 
AATYGGAAGTGGTYGYGYGGYGGTAGTGTAGGTTTATATA
TTATAGTT
CpG1
4%
CpG1
24%
CpG1
95%
CpG1
4%
CpG2
4%
CpG2
24%
CpG2
98%
CpG2
2%
CpG3
6%
CpG3
27%
CpG3
97%
CpG3
5%
CpG4
9%
CpG4
22%
CpG4
100%
CpG4
10%
CpG1
99%
CpG2
100%
CpG3
78%
CpG4
37%
CpG5
78%
CpG1
97%
CpG2
100%
CpG3
80%
CpG4
37%
CpG5
78%
Infertile 
patient 2
CpG1
8%
CpG2
10%
CpG3
13%
CpG4
15%
CpG1
88%
CpG2
100%
CpG3
70%
CpG4
36%
CpG5
68%
Figure 4 Pyrograms showing methylation level for each cytosine within the investigated sequences in spermatozoa of one fertile donor
and two selected infertile patients. In contrast to the hypomethylated promoter region of NSD1, paternally imprinted and hypermethylated H19
locus is presented as a control. Pyrosequencing using fully methylated and fully unmethylated DNA was carried out for the internal control.
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Figure 5 DNA methylation level of investigated H4K12ac interacting promoters in spermatozoa from n = 8 fertile donors and n = 39
subfertile patients - pyrosequencing. While the group of fertile donors represented a stable methylation pattern, a large disproportion and
high standard deviation were observed in the group of subfertile men.
Figure 6 The methylation level in each cytosine in sperm DNA was analyzed by pyrosequencing. (A) DNA methylation in 12 cytosines
(CpG) in H4K12ac-associated NSD1 promoter in fertile donors and subfertile patients. (B) Averaged DNA methylation in 1 to 4 CpGs and 5 to 12
CpGs of NSD1 promoter in fertile and subfertile men. (C) DNA hypermethylation in 12 CpGs in sperm-specific protamine promoter. (D) Averaged
methylation from 12 CpGs in protamine promoters showing no significant difference between fertile and subfertile sperm.
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Table 2 Semen characteristics of 39 men with unexplained infertility
Mean SD Median Minimum Maximum
Sperm parameters of subfertile patients and ICSI outcomes
Volume (ml) 4.38 2.46 4 0.5 10
Sperm count (× 106/ml) 41.12 29.9 32 3.9 140
Total sperm count (× 106) 150.2 120 140.7 21.45 702
Total motility (%) 36.7 15.94 35 67 10
Progressive motility 7.12 5.7 7 0 18
Morphology normal forms (%) 10.03 5.16 10 24 2
Aniline blue staining (2 + 3) 48.4 15.8 45 20 76
ICSI outcomes of subfertile men
Number of oocytes 6.94 3.96 7 22 2
First pronucleus stage 4.20 4.0 2.51 13 1
Second pronucleus stage 3.79 2.17 3.0 10 1
Fertility rate (%) 58.44 24.16 57.14 20 100
Number of embryos transferred 2.17 0.60 2.0 3 1
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promoter (Table 3). POU2F DNA methylation correlated
negatively with progressive sperm motility (R = −0.43;
P = 0.023). Although not significant, but still notice-
able, negative correlation could be observed in POU2F
DNA methylation and in sperm concentration (R = −0.30;
P = 0.121). A similar trend of negative correlation could be
seen with POU2F DNA methylation and the fertility rate
(R = −0.33; P = 0.08). Protamine DNA methylation as a
‘non-histone’ associated promoter was strongly correlated
with the fertility rate (R = 0.71; P = 0.003), and a tentative
positive correlation could be observed with protamine
DNA methylation and sperm concentration (R = 0.41;
P = 0.138).
Paternally derived H4K12ac pattern resembles global
DNA demethylation in male pronucleus shortly after
fertilization (mouse model)
In order to study the transmission of epigenetic marks
from paternal chromatin (predominantly H4K12ac andTable 3 Correlations between methylation in sperm DNA with
parameters, and fertility rates
Promoter Sperm concentration (× 106/ml) Sperm m
AFF4 R = −0.25; P = 0.232 R = −0.04;
NCOA6 R = −0.07; P = 0.677 R = 0.24; P
RUVBL1 R = −0.05; P = 0.767 R = −0.03;
NSD1 R = −0.32; P = 0.071 R = −0.05;
USP9X R = −0.03; P = 0.865 R = 0.01; P
POU2F R = −0.30; P = 0.121 R = −0.43;
Protamine R = 0.41; P = 0.138 R = 0.12; P
Significant values when *P ≤ 0.05 and **P ≤ 0.01.DNA methylation) to the embryo, we used a mouse
in vitro fertilization model followed by indirect im-
munofluorescence. Spermatozoa before fertilization,
and pronuclei in early developmental pronuclear stages
(PN3-PN5) prior to fusion and division, were subjected
to immunostaining. In sperm, the fluorescence signal
was clearly detectable in the postacrosomal region of
the sperm head over the central part of the nucleus
(green) (Figure 7). Interestingly, we identified the same
localization for 5-methylcytosine (5mC) signal (red)
(Figure 7), suggesting that these epigenetic marks occupy
the same compartment of the mouse sperm nucleus.
The localization of H4K12ac in mouse-fertilized eggs
with clearly established pronuclei was analyzed. The
male and female pronuclei were distinguished by their
naturally differing size, with the male pronucleus being
larger than the female pronucleus. Starting from the
time when pronuclei are formed, the paternal one ex-
hibits a strong signal for H4K12ac (Figure 8A), while in
the maternal pronucleus, there is a continual increase ofin different H4K12ac-associated promoters, ejaculate
otility Sperm morphology Fertility rate (ICSI)
P = 0.821 R = 0.08; P = 0.692 R = −0.272; P = 0.18
= 0.183 R = 0.15; P = 0.387 R = 0.06; P = 0.72
P = 0.870 R = −0.28; P = 0.138 R = 0.36; P = 0.05
P = 0.976 R = −0.17; P = 0.326 R = 0.22; P = 0.21
= 0.943 R = −0.39; P = 0.072 R = 0.17; P = 0.42
P = 0.023* R = −0.24; P = 0.217 R = −0.33; P = 0.08
= 0.689 R = −0.12; P = 0.976 R = 0.71; P = 0.003**
Figure 7 Immunofluorescent labeling of H4K12ac and 5-methylcytosine (5mC) in mouse sperm nucleus. Double stained spermatozoa
with anti-H4K12ac antibody (green) (A), anti-5mC antibody (red) (B), merged with DAPI (C), and merged with DIC (D).
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taneously, there is a continual decrease of the DNA
methylation state in the paternal pronucleus indicated
by an increase of the 5-hydroxymethylcytosine (5hmC)
signal (Figure 9A, E) and a decrease of the 5mC signal
(Figure 9B, F). Meanwhile, the maternal pronucleus be-
comes widely methylated (Figure 9B, F). DNA demethyl-
ation and acetylation on lysine K12 of histone H4 are
genome activating modifications underlying differences
in the transcription activity of the pronuclei. After gam-
ete fusion in the two-cell stage, a homogenous staining
for H4K12ac and 5mC was observed (Figure 8I, J, K). A
similar pattern was detected for 5mC and 5hmC (Figure 9I,
J, K). Pronuclei of parthenogenetically activated oocytes
show the ability to substitute paternal H4K12ac, and the
degree of DNA demethylation is higher than in the mater-
nal pronucleus of the control zygote (Additional file 2).Figure 8 Immunofluorescent labeling of H4K12ac and 5-methylcytosi
anti-H4K12ac antibody (green) (A, E, I), anti-5mC antibody (red) (B, F, J), m
PN3. (E-H) Pronucleus at stage PN5. (I-L) Two-cell embryo. Maternal pronuThis fact suggests the important role of H4K12ac for the
accumulation of transcription factors and the regulation
of gene expression during early embryogenesis.
Discussion
The sperm epigenome has recently been the subject of
intensive investigations in research laboratories of repro-
ductive medicine/biology. Although extensive progress
has been made in the understanding of sperm chromatin
packaging into protamine toroids [17], genome-wide
histone retentions [10,11,19] and DNA methylation [20]
epigenetic factors of infertility and their effect on
embryogenesis still remain to be elucidated. This study
demonstrates that a loss of binding sites for H4K12ac in
selected developmentally important promoters in the
sperm of subfertile men gives rise to the idea of a pos-
sible epigenetic aberration that sperm of subfertile menne (5mC) in mouse early embryos. Double stained embryos with
erged (C, J, K), merged with DIC (D, H, L). (A-D) Pronucleus at stage
cleus (♀) and paternal pronucleus (♂). Scale bar represents 20 μm.
Figure 9 Immunofluorescent labeling of 5-hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC). Double stained embryos with
anti-5hmC antibody (green) (A, E, I), anti-5mC antibody (red) (B, F, J), merged (C, J, K), merged with DIC (D, H, L). (A-D) Pronucleus at stage
PN3. (E-H) Pronucleus at stage PN5. (I-L) Two-cell embryo. Maternal pronucleus (♀) and paternal pronucleus (♂). pb, polar body. Scale bar
represents 20 μm.
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hypomethylation of all H4K12ac interacting promoters.
This methylation pattern has been conserved in the
population of subfertile sperm. While sperm DNA
methylation of normozoospermic men displayed low
standard deviation, a higher variability in the percent-
age of methylation was detected in the promoters of
subfertile men; however, 30% of methylation was not
exceeded. In contrast, cytosines within the CpG island
of the protamine gene were hypermethylated, and no
changes between healthy donors and subfertile patients
were detected. Furthermore, the relevance of sperm
derived H4K12ac for pronucleus formation and its
resemblance to DNA demethylation was confirmed by
immunofluorescence in the mouse model.
The loss of H4K12ac enrichment in a genome-wide
manner and in specific loci may have its origins in either
improper remodeling during spermatogenesis or a de-
creased activity of histone acetyl transferases (HATs)
and histone deacetylases (HDACs).
Interestingly, a reduced binding, of H4K12ac to EP300
and LRP5 promoters, was compensated by protamines.
On the other hand, sperm phenotypes with over 50% an-
iline blue staining suggest that there is an increased
amount of total histones in subfertile spermatozoa. The
principle of the aniline blue staining is to differentiate
between lysine-rich histones and arginine/cysteine-rich
protamines. Aniline blue stain lysines of histone-rich
nuclei of immature spermatozoa, where protamine-richnuclei of mature spermatozoa containing relatively low
levels of lysine, do not display staining [21]. The reduced
binding of H4K12ac to developmentally important pro-
moters might be explained by a possible loss of lysine 12
acetylation. The acetyl group counteracts the positive
charge of the epsilon-amino group of the lysine, redu-
cing the overall charge of histones, and decreases their
affinity for the negatively charged DNA. This causes the
opening of chromatin and the facilitation of the recruit-
ment of the transcriptional machinery [22]. As sperms are
transcriptionally inactive cells, interaction with H4K12ac
within developmentally important promoters may facili-
tate the recruitment of factors initiating transcription.
Whether acetylation itself is only associated with gene
activation is still not certain because it has been recently
shown that protamines also contain acetyl groups [23].
The data also identify post-translational modifications,
such as S42 and K49 acetylation of protamine-1 and K64
acetylation on protamine-2 [23]. The fact that protamines
carry marks associated with transcriptional activation is
intriguing, as these proteins are thought to ensure tight
packaging of the DNA in sperm cells and contribute to
transcriptional silencing [24].
The clinical aspects of histone modifications interact-
ing with promoters in sperm of infertile men are not yet
well addressed in the literature. Besides our group,
Hammoud et al. (2011, 2009) [10,25] have evaluated the
differences in sperm histone modifications between healthy
donors and men who displayed aberrant protamine P1/P2
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during in vitro fertilization (IVF) [26]. Analyzing H3 lysine
4 methylation (H3K4me) or H3 lysine 27 methylation
(H3K27me), the authors reported a highly similar
localization pattern in the gametes of infertile men
compared to fertile men. However, there was a reduc-
tion in the amount of H3K4me or H3K27me retained
as developmental transcription factors and certain
imprinted genes, which appear to be in agreement with
our results. Analyzing the distribution of H3K9ac in
the sperm genome, using ChIP in combination with
ENCODE array, we identified interactions in develop-
mentally relevant promoters (FAM50A, CAV1, HOXA13,
TH, MET, SF1, AFF4, HCFC1, INHA, ELL3, WNT2,
CTTNBP2, HOXA10, THOC2, AXIN1) and exonic and
intergenic sequences. In our previous study, random dis-
tribution and depletion of H3K9ac interaction in many
loci (for example, CTSD, FLNA, MCF2L, PLXNA3,
SG3GLB2, TH) of infertile men sperm have been con-
firmed [27]. Findings obtained from our own and other in-
vestigators’ studies suggest an aberrant distribution of
histone retentions in the genome of subfertile men, and
this seems to be a common observation for several histone
modifications.
To examine whether a depletion of binding sites for
H4K12ac in developmentally important promoters might
result in a change in DNA methylation, pyrosequencing
of 9 candidate developmental loci that lacked or had sig-
nificantly reduced levels of H4K12ac and the protamine
promoter were assessed in 38 subfertile men. H4K12ac
promoters of fertile and subfertile men were correlated
with DNA hypomethylation; however, they were display-
ing a more concordant methylation pattern compared to
subfertile patients. The loss of binding sites obviously
does not cause a gain of DNA methylation, or possibly,
these promoters are protected by other histone modifi-
cations, as for instance, H3K4me. A most intriguing ob-
servation obtained from our results was that single CpG
methylation was stable in every selected promoter of the
fertile group, while methylation of subfertile patients
showed considerable variation within the same group.
Methylation studies, using pyrosequencing methods fo-
cused on different loci MEST and IGF2⁄H19 ICR1, showed
the same effect in the group of subfertile patients [28].
Genome-wide shotgun bisulfite sequencing from sperm
DNA provides evidence that the majority of promoters in
sperm, similarly to embryonic stem cells, escape methyla-
tion. In contrast, repeat elements are strongly methylated
in both germ and somatic cells; however, retrotransposons
from several subfamilies evade methylation more effect-
ively during male germ cell development [20]. In respect
to male infertility, several research approaches have
pointed out that imprinted regions were more prone to
deregulation of methylated pattern than promoter regions[25,26,29] Nevertheless, the specific promoters including
CREM have been shown to possess a significantly higher
rate of methylation in patients with abnormal protamina-
tion and oligozoospermia compared to the control group
[30]. This study investigated a large cohort of 175 oligo-
zoospermic men and demonstrated epimutations in
H19-DMR and PEG1/MEST-DMR in 20% and 3% of
oligozoospermic men, respectively. The authors identi-
fied an amino acid change, in DNMT3A in one case and
altered methylation profiles in DNMT3L in eight men,
as a possible cause of epimutations. Interestingly, no
correlation between the ART outcome and epimutations
was found [31].
Finally, in the present study, the relevance of the co-
existence of paternally derived chromatin active marks
(H4K12ac) and 5hmC in the early pronucleus stages of
the mouse embryo was demonstrated. The paternal pro-
nucleus displays a high level of H4K12 acetylation,
which interferes with global demethylation. This fact
may give rise to the idea that developmentally relevant
promoters in sperm occupied with H4K12ac and with a
moderate level of methylation may be prepared for the
transmission of certain epigenetic marks to the embryo.
Recent reports from zebrafish embryos strengthen the
hypothesis that sperm DNA methylome, but not oocyte,
is inherited during early embryo formation [32]. A previ-
ously proposed and generally accepted theory is that the
paternal pronucleus is demethylated through the active
process by the conversion of 5mC to 5hmC catalyzed by
Tet3 and the maternal pronucleus through DNA
replication-dependent demethylation [33,34]. According
to our results, the paternal pronucleus is widely demethy-
lated before the onset of the first DNA replication at PN3.
This happens independently, although, 5hmC in the pater-
nal pronucleus is removed during DNA replication in a
passive manner [35]. Indeed, the paternal pronucleus pos-
sessed a higher level of 5hmC than the maternal pro-
nucleus, which is evident in all PN stages by strong 5mC
labeling. However, the level of 5hmC continually increased
during the replication phase. An explanation of this in-
creasing intensity may be that 5hmC could participate in
passive demethylation, and the evidence is that Dnmt1
poorly recognizes 5hmC [36].
Conclusions
Given the well-known heterogeneity of sperm cells within
one ejaculate, as well as the multifactorial background of
male infertility, we included sperm samples with aberrant
sperm chromatin condensation assessed by using aniline
blue staining as the subject of the study. Similarly, in order
to define the phenotypes of patients with considerable
impaired transmission of epigenetic marks to the em-
bryo, we analyzed sperm of patients who had not ob-
tained pregnancy after ICSI treatment. According to our
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epigenetic alteration than cytosine methylation within
developmentally relevant promoters. Considering the
activating properties of H4K12ac in the regulation of
developmentally important genes in the early embryo
and the establishment of an open chromatin frame, to-
gether with DNA hypomethylation, we speculate that
H4K12ac could represent a potential factor for epigenetic-
mediated infertility.
Methods
Ejaculates were obtained from 39 patients, whose female
partners took part in an ICSI program in Fertility Centers
in Wetzlar and Wiesbaden. All the samples were collected
according to the current version of the Declaration of
Helsinki, and informed written consent was obtained from
every patient before being included in the study. The
experimental procedure of using patients’ ejaculates was
approved by the Ethics Committee of the Medical Faculty
of Justus-Liebig-University (approval 146/06 confirmed
on 15 December 2010 for studies of German Research
Foundation (DFG), Project 1 of the Clinical Research
Unit KFO 181/2).
The control group comprised of nine healthy volunteers
with normozoospermia, according to the current World
Health Organization (WHO) reference values [37] (WHO,
2010). Hence, semen characteristics from these men are
considered as surrogate parameters reflecting normal
fertility.
Spermiogram parameters according to the recommen-
dations of WHO (2010) [38] were available (Table 2).
Sperm morphology was evaluated according to strict cri-
teria. The total motile sperm count was calculated as the
product of volume. The sperm concentration and pro-
gressive motility of native semen were assessed. In order
to assess the histone and protamine status in sperm,
chromatin standard aniline blue staining was conducted
[21]. The protamine mRNA ratio was measured from 14
out of 40 patients. Fertility parameters after the ICSI
program were registered. The number of oocytes, first
and second pronuclear stages, a number of embryos,
and the percentage of fertilized oocytes (fertility rate)
and pregnancy outcomes were collected (Table 2).
Strict selection criteria have been applied for subfertile
patients regarding epigenetic fertility factors, which were
investigated in this project. Men diagnosed with idiopathic
infertility with aberrant sperm chromatin condensation as
assessed by aniline blue staining 2 + 3 > 50%, as well as no
pregnancy resulting from ICSI, and 4 out of 20 ICSI cycles
ended in an abortion, were included in this study.
μ-ChIP
For the handling of a small number of sperm cells in
subfertile patients, we used a modified version of theQ2ChIP assay. For that, we used a LowCell# ChIP Kit
from Diagenode (Cat.No. kch-maglow-A16, Diagenode,
Sparta, NJ, USA). Eleven microliters of protein A-coated
magnetic beads was washed twice in 22 μl of ice-cold
RIPA buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1%
Triton X-100, 0.1% SDS, 0.1% Na-deoxycholate, 100 mM
NaCl). Then, 2.4 μg of the antibodies were added, followed
by a 2-h incubation at 4°C. In this study, we used poly-
clonal IgG ChIP grade (ab46540, Abcam, Cambridge, UK)
as a negative control and antibodies against unmodified
histone H3 (ab1791, Abcam, Cambridge, UK) as a positive
control. ChIP grade rabbit polyclonal antibodies against
acetylated histone H4 at lysine 12 (H4K12ac) were used
for immunoprecipitation and were purchased from
Abcam (ab1761, Abcam, Cambridge, UK). Anti-protamine
1 (PRM1) antibodies (Hub 1 N) were purchased from
Briar Patch Biosciences, Livermore, CA, USA.
The respective ejaculate was centrifuged for 10 min at
4,000 rpm/4°C to collect the sperm cells. The super-
natant was discarded, and the cells were washed twice
with 1 ml PBS+, which means phosphate-buffered saline
(PBS) including 20 mM butyrate and protease inhibitor
(Complete Mini EDTA-free, 04693150001, Roche,
Mannheim, Germany), for 10 min at 4,000 rpm/4°C.
Then, 500 μl of PBS+ and 13.5 μl of 36.5% formalde-
hyde were added for crosslinking. After 8 min at room
temperature, 57 μl of 1.25 M glycine was added to stop
the fixation. After 5-min incubation followed by centri-
fugation at 6000 × g for 10 min at 4°C, the supernatant
was discarded and the cells were washed twice in
0.5 ml of ice-cold PBS+. Then, 120 μl of lysis buffer
(50 mM Tris-HCl, pH 8, 10 mM EDTA, 1% SDS, prote-
ase inhibitor cocktail, 20 mM butyrate) and glass beads
(G1277, Sigma-Aldrich, Seelze, Germany) were added
and incubated on ice followed by a treatment of
Bioruptor sonicator (UCD-200 TO, Diagenode, Sparta,
NJ, USA) (25 cycles of: (30 s ‘ON,’ 30 s ‘OFF’)). After
sonication, the samples were supplemented with 480 μl
of RIPA ChIP buffer (RIPA buffer including 20 mM
butyrate and protease inhibitor) and centrifuged at
12,000 × g for 10 min at 4°C. While the supernatant
was transferred to a new tube, the pellet was washed
with 330 μl RIPA ChIP buffer as before, resulting in a
second supernatant that was pooled with the first one.
The sheared chromatin was then incubated with anti-
bodies. For this, 100 μl of sheared chromatin was incu-
bated with 10 μl of pre-washed antibody-coated magnetic
beads on a rotating wheel for 2 h at 40 rpm at 4°C. Then,
the sample was washed three times with 100 ml of RIPA
buffer by centrifugation for 4 min. Finally, the sample was
washed with TE buffer in the same way.
To isolate DNA from histones, 100 μl of DNA isolation
buffer (20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 20 mM
sodium butyrate, 50 mM NaCl, 1% SDS, 50 μg/ml
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bation step at 55°C/15 min and 100°C/15 min. Subse-
quently, the sample was centrifuged with 14,000 rpm for
5 min at 4°C. The supernatant was then ready for succes-
sive qPCR analysis.
Validation of enriched promoters with ChIP in combination
with real-time polymerase chain reaction
To validate the ChIP assays, we performed quantitative
real-time PCRs. For this, primers for enriched se-
quences, including 1 kb upstream and downstream from
the peak center, were generated. Primer sequences were
published in our previous work [12]. Additionally, we
performed ChIP assays with chip-grade antibodies
against protamine-1 (catalog no. MAb-001, Briar Patch
Biosciences, Livermore, CA, USA). Two microliters of
immunoprecipitation sample was used for the PCR re-
action with 10 pmol/μl of each primer, 12.5 μl iQTM
SYBR Green Supermix (catalog no.170-8882, Bio-Rad,
Hercules, CA, USA) in 23 μl of the total volume. For
the PCR, we choose the following conditions: an initial
step of 3 min at 95°C, followed by 40 cycles of 30 s at
95°C, 30 s at 58°C to 62°C, and 1 min at 72°C. Furthermore,
PCR products were checked by sequencing (Scientific
Research and Development GmbH).
Calculations for graphs were processed as follows: A
threshold was set in the log-linear range for all reactions.
The cycle number at which one of the individual PCR
reactions reaches this fixed threshold is defined as the
Ct-value. To see the enrichment of the immunoprecipi-
tated sample compared to input material, the following
calculation was made: ΔCt =Ct (input) - Ct (immunopreci-
pitated sample) and % total = 2ΔCt × 10 (according to 10%
input chromatin of total immunoprecipitated chromatin).
Pyrosequencing
To quantify the methylation of single CpGs, 20 ng of
bisulphate-treated DNA was amplified by PCR with
specific primers. These primers were part of the ready-to-
use assays provided from Qiagen, Hilden, Germany. We
used the following assays: Hs_NSD1_01 (PM00022988),
Hs_USP9X_01 (PM00033257), Hs_POU2F1_05 (PM0008
9103), Hs_RUVBL1_01 (PM00109172), Hs_AFF4_02
(PM00115024), Hs_LRP5_03 (PM00154007), Hs_NCOA6_01
(PM00198044), and Hs_EP300_02 (PM00199731). Add-
itionally, we designed another primer pair for AFF4 to in-
vestigate more CpGs in that CpG island. Furthermore,
two primer pairs for the protamine-1 promoter region
were custom-designed. These three primers were designed
with Qiagen (Qiagen, Hilden, Germany) ‘PyroMark Assay
Design’ software (Version 2.0.1.15) and are shown in
Table 4.
The PCR reaction contained 12.5 μl of PyroMark
PCR Master Mix (Qiagen, Hilden, Germany), 2.5 μl ofCoralLoad (Qiagen, Hilden, Germany), and 2.5 μl of
0.2 μM primer mix, together with DNA diluted with
ddH2O in to a final volume of 25 μl. The following
conditions were used for PCR: 95°C for 15 min
followed by 45 cycles at 95°C for 30 s, 56°C for 30 s,
and 72°C for 30 s and a final extension at 72°C for
10 min. The PCR products were pyrosequenced in Qia-
gen PyroMark Q24. We used the standard protocol
and the required chemicals supplied by Qiagen. The
sequencing primers were part of the previously de-
scribed assays. The received data was analyzed by
Qiagen Q24 software (Version 2.0.6) (Qiagen, Hilden,
Germany).
Immunostaining of mouse spermatozoa with anti-H4K12ac
and anti-5mC antibodies
Spermatozoa were obtained from C57Bl/6mice at the
age of 4 to 6 months. Sperm from the caudae epididy-
midae was extracted in to 1 ml of TBS followed by
centrifugation for 8 min at 3,000 rpm. The pellet was
re-suspended with PBS and diluted in distilled water.
Five-microliter droplets were smeared onto a glass
slide and dried for 2 h at room temperature (RT).
Smears were covered by a freshly prepared deconden-
sing mix (25 mM DTT, 0.2% Triton X-100, and 200 IU
heparin/ml) and incubated at 37°C under 5% CO2 for
12 to 15 min according to the state of the decondensa-
tion, which was monitored under a light microscope.
The decondensation was stopped by the fixation of
sperm in 3.7% paraformaldehyde for 20 min followed
by washing in PBS. The prepared slides were blocked
with 10% goat serum in PBS for 2 h at RT, washed and
covered by a mixture of anti-5mC (BI-MECY-0500
Eurogentec, Cologne, Germany) and anti-H4K12ac anti-
bodies (ab61238, Abcam, Cambridge, UK) (both antibody
in the dilution of 1:500 in PBS) and incubated for 2 h at
RT. After the washing steps, 10 times in PBS, secondary
antibodies with fluorescein thiocyanate (FITC) conjugate
(goat polyclonal secondary antibody to rabbit IgG - H&L
(FITC), ab6717, Abcam, Cambridge, UK) and Alexa Fluor®
568 Goat Anti-Mouse IgG (H + L) A-11004, Molecular
Probes, Invitrogen, Karlsruhe, Germany) were diluted
1:1,000 in PBS and slides were incubated for 1 h. After
washing, slides were mounted with VECTASHIELD
mounting medium for fluorescence with DAPI (H-300,
Vector Laboratories, Inc., Burlingame, CA, USA).
Mouse in vitro fertilization and immunostaining of mouse
pronuclei
C57Bl/6 mice were obtained from a breeding colony of
the Laboratory of Reproduction, Faculty of Science,
Charles University in Prague. All animal procedures
were carried out in strict accordance within the law of
the Czech Republic, paragraph 17 no. 246/1992, and
Table 4 Primers designed for pyrosequencing
Gene Primers Sequence to analyze PCR product size (bp)
PRM_1 F 5′-GGG GTG GTT AGG GAT ATG T-3′ ATTTYGTGYGAGYGTTYGTTTAGGTTTTTTAYGYG
GTATYGGATTATGGTGTTGGGAGATTTGGTGG
335
R Bio5′-CAC CAA ATC TCC CAA CAC CAT-3′
S 5′-ATG TAA TTG TTG TTT GTA T-3′
PRM_2 F Bio5′-GGG GTG GTT AGG GAT ATG T-3′ ACCRAATCCACAAACRACAACATCRCTCCTACA
AAAAACRCAAAAAACRCTCCTACAAACACC
182
R 5′-AAA AAC CCA TAA CCA ATC TCA CTA TAA-3′
S 5′-CAC TAC TCT CCA AAA AAA CTA C-3′
AFF4 F 5′-GGG TTA GGG TTG GGA TAG TTG A-3′ TTYGTTTYGTTYGTTGGYGGYGGYGAYGGTAGTT
GGATTTTTGTAGTTAGGGT
229
R Bio5′-AAA CCC CCC CCC CCT ACT-3′
S 5′-GAA GAT TTG GTA TTA GGA TT-3′
H19_4 F 5′-GGGGGTTTTTGTATAGTATATGGGT-3′ AATYGGAAGTGGTYGYGYGGYGGTAGTGTAGG
TTTATATATTATAGTT
242
R Bio5′-ACTCCTATAAATATCCTATTCCCAAAT-3′
S 5′-GGAATTGGTTGTAGTTGTGG-3′
NSD1m1 F 5′-AGTTGAGGATTTAGTAGGTTTGTATTTAG-3′ GTGTAGTYGTTTYGGTYGGTTYGTTTGYGGTTTGY
GTATYGTYGTTGTAAAGGTTT
173
R Bio5′-TACCCCCCCCTTCCTAACT-3′
S 5′-GGAAGGAGAGTTTTGGG-3′
Table shows sequence to analyze and size of the PCR amplicons. F: forward primer; R: reverse primer; S: sequencing primer; Bio: biotinylation.
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and the Local Ethics Committee of the Faculty of Science
of Charles University in Prague specifically approved
this study in accordance with accreditation no. 24773/
2008-10001.
While male mice were within a reproductive age of 10
to 12 weeks, the female mice used for hormonal stimula-
tion were 21 days old. For the in vitro fertilization, the
isolated eggs from the oviduct of juvenile hormonally
stimulated females (strain C57Bl/6) were added to ca-
pacitated sperm gained from the distal region of cauda
epididymis for fertilization. Zona pellucida was removed
by Tyrodes solution (catalog no. T1788, Sigma-Aldrich,
Seelze, Germany), and the eggs were fixed for 20 min in
2.5% paraformadehyde. TritonX-100 (0.1%) in PBS was
added for 10 min to wash and permeabilize the eggs.
After blocking with goat serum, embryos and eggs were
washed three times with 0.05% Tween in PBS incubated
with primary antibodies. A mixture of anti-5hmc (39769,
Active Motif, Rixensart, Belgium) and anti-5mC (BI-
MECY-0500 Eurogentec, Cologne, Germany) antibodies
(dilution 1:1000 both) was applied. Other embryos were
stained with anti-H4K12ac (ab61238, Abcam, Cambridge,
UK) and anti-5mC (BI-MECY-0500 Eurogentec, Cologne,
Germany) (dilution 1:1,000 in 1% goat serum in PBS).
Eggs and embryos were incubated with primary antibodies
for 3 h in RT and then washed three times in 0.05% Tween
in PBS. Secondary antibodies Alexa Fluor 488 (FITC) goat
anti-rabbit IgG (A-11008, Molecular Probes, Invitrogen,
Karlsruhe, Germany) and Alexa Fluor 568 goat anti-
mouse IgG, (A-11004, Molecular Probes, Invitrogen,
Karlsruhe, Germany) or secondary antibodies anti-rabbitIgG (FITC), (ab6717, Abcam, Cambridge, UK) and Alexa
Fluor 568 Goat anti-Mouse IgG (A-11004, Molecular
Probes, Invitrogen, Karlsruhe, Germany) were diluted
1:1,000 in PBS. Incubation with secondary antibodies was
held for 1 h, and eggs were then washed three times
in 0.05% Tween in PBS and mounted on slides with
VECTASHIELD mounting medium for fluorescence
(H-100, Vector Laboratories, Inc., Burlingame, CA,
USA). Samples were examined with a Leica DM IRE2
(Leica, Heidelberg, Germany) high-speed confocal/two
photon system for Live Cell Imaging.
Statistics
The Mann-Whitney U-test was applied in order to com-
pare the enrichment of μChIP assay between the groups
of fertile and infertile patients. The same Mann-Whitney
U-test was performed for the comparison of methylation
levels in promoters between fertile donors and subfertile
patients as values were not normally distributed. Correla-
tions of clinical parameters with cumulative methylation in
each investigated promoter were tested by non-parametric
Spearman’s rho correlation. Differences were considered
significant when P < 0.05. Statistical calculations were per-
formed using GraphPad Prism, version 5.02 for Windows
(GraphPad Software, San Diego, CA, USA).
Additional files
Additional file 1: Methylation analysis of the selected H4K12ac
interacting promoters POU1F2, NCOA6, LRP5, EP300, USPX9, and
RUVBL1. A: The enrichment of binding sites for selected H4K12ac-associted
promoters in sperm chromatin of fertile and subfertile men (ChIP-chip assay
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log2 ratio that was calculated from the input signal Cy3 for the total of
chromatin and IP probe - Cy5, which were co-hybridized to the array. The
log2 ratio was computed and scaled to the center the ratio data around
zero. Scaling was performed by subtracting the bi-weight mean of the log2
ratio values for all features on the array from each log2 ratio value. The
binding sites for H4K12ac to sperm chromatin were detected by searching
for four or more oligo probes whose signals were above the specific cut off
values, ranging from 90% to 15%, using a 500-bp sliding window. The ratio
data were randomized 20 times, and each peak was assigned a false
discovery rate (FDR) score based on the randomization. The lower the FDR
score, the more likely the peak corresponded to a H4K12ac binding site.
Data are visualized using SignalMap browser (NimbleGen). B: Genomic
position of analyzed CpGs within CpG islands of selected genes -
pyrosequencing. C: Methylation levels of each investigated CpG in
sperm DNA of fertile and subfertile patients.
Additional file 2: Figure demonstrating immunofluorescent
labeling of nuclei of parthenogenetically activated oocytes. Nuclei
stained with antibody anti-H4K12ac (green) (A), DAPI (blue) (B), merged
(C), merged with DIC (D); antibodies anti-H4K12ac (E), anti-5mC (F),
merged (G), merged with DIC (H); and antibodies anti-5hmC (I), anti-5mC
(J), merged (K), merged with DIC (L).
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